Hangzhou Biotest Biotech Revenue

In the year 2025, Hangzhou Biotest Biotech had annual revenue of 448.37M CNY, down -19.85%. Hangzhou Biotest Biotech had revenue of 140.30M in the quarter ending December 31, 2025, a decrease of -17.77%.

Revenue

448.37M

Revenue Growth

-19.85%

P/S Ratio

11.94

Revenue / Employee

743.57K

Employees

622

Market Cap

5.36B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	448.37M	-111.03M	-19.85%
Dec 31, 2024	559.40M	117.29M	26.53%
Dec 31, 2023	442.11M	-1.46B	-76.75%
Dec 31, 2022	1.90B	83.07M	4.57%
Dec 31, 2021	1.82B	952.70M	110.09%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Wuhan Hvsen Biotechnology	1.67B
ChemPartner PharmaTech	1.07B
PharmaResources (Shanghai)	667.47M
Jiangsu Bioperfectus Technologies	340.38M
Novogene	2.17B
Shouyao Holdings (Beijing) Co., LTD.	8.67M
Beijing Bohui Innovation Biotechnology Group	834.38M
Kexing Biopharm	1.54B

Revenue Rankings